These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9892485)

  • 21. Custodial-HTK Solution for Myocardial Protection in CABG Patients.
    Prathanee S; Kuptanond C; Intanoo W; Wongbhudha C; Karunasumaeta C
    J Med Assoc Thai; 2015 Aug; 98 Suppl 7():S164-7. PubMed ID: 26742385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative Analysis of Myocardial Protection with HTK Solution and Hypothermic Hyperkalemic Blood Solution in the Correction of Acyanogenic Congenital Cardiopathies - A Randomized Study.
    Valente AS; Lustosa GP; Mota LAM; Lima A; Mesquita FA; Gondim A; Rodrigues FA; Pompeu RG; Branco KC
    Braz J Cardiovasc Surg; 2019 Jun; 34(3):271-278. PubMed ID: 31310464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cardioprotective effects of cariporide as an adjunct in different cardioplegic solutions: an experiment with rabbits].
    Zhou RH; Long C; Liu J; Liu B
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(33):2320-3. PubMed ID: 18036293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The nitric oxide donor, S-nitroso human serum albumin, as an adjunct to HTK-N cardioplegia improves protection during cardioplegic arrest after myocardial infarction in rats.
    Trescher K; Dzilic E; Kreibich M; Gasser H; Aumayr K; Kerjaschki D; Pelzmann B; Hallström S; Podesser BK
    Interact Cardiovasc Thorac Surg; 2015 Mar; 20(3):387-94. PubMed ID: 25468794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Superior myocardial protection with a new histidine-buffered crystalloid cardioplegic solution in clinical trial.
    Takeuchi K; Maida K; Tanaka S; Yoshida S; McGowan X; del Nido PJ
    Thorac Cardiovasc Surg; 1999 Jun; 47(3):148-52. PubMed ID: 10443514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Protective effect of cold autologous blood cardioplegic solution on the heart of infants with cyanotic congenital heart disease].
    Ma C; Shen DR; Zhang Q; Meng XC; Wang YX; Peng L; Meng BY
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jun; 15(6):453-7. PubMed ID: 23791061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histidine-tryptophan-ketoglutarate solution decreases mortality and morbidity in high-risk patients with severe pulmonary arterial hypertension associated with complex congenital heart disease: an 11-year experience from a single institution.
    Li XW; Lin YZ; Lin H; Huang JB; Tang XM; Long XM; Lu WJ; Wen ZK; Liang J; Li DY; Zhao XF
    Braz J Med Biol Res; 2016; 49(6):e5208. PubMed ID: 27191607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deleterious effect of hypothermia in myocardial protection against cold ischemia: a comparative study in isolated rat hearts.
    Lima ML; Fiorelli AI; Vassallo DV; Batista PR; Simoes FV; Fiorim J; Stefanon I; Pinheiro BB; Stolf NA; Gomes OM
    Transplant Proc; 2012 Oct; 44(8):2326-32. PubMed ID: 23026585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolonged hypothermic cardiac storage with histidine-tryptophan-ketoglutarate solution: comparison with glucose-insulin-potassium and University of Wisconsin solutions.
    Ku K; Oku H; Alam MS; Saitoh Y; Nosaka S; Nakayama K
    Transplantation; 1997 Oct; 64(7):971-5. PubMed ID: 9381543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficiency of heart protection with HTK or HTK-N depending on the type of ischemia.
    Schaefer M; Gebhard MM; Gross W
    Bioelectrochemistry; 2019 Feb; 125():58-69. PubMed ID: 30265864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative evaluation of clinical use of cardioplegic solutions custodiol and konsol in the correction of cardiac valvular diseases].
    Zhidkov IL; Kozhevnikov VA; Ivanov VA; Morozov IuA; Andrianova MIu; Van EIu; Trekova NA
    Anesteziol Reanimatol; 2006; (2):13-8. PubMed ID: 16758937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heart preservation in HTK solution: role of coronary vasculature in recovery of cardiac function.
    Saitoh Y; Hashimoto M; Ku K; Kin S; Nosaka S; Masumura S; Nakayama K
    Ann Thorac Surg; 2000 Jan; 69(1):107-12. PubMed ID: 10654496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of the protective prorerties of St. Thomas', Tyers', and Bretschneider's cardioplegic solutions in the neonatal rabbit heart].
    Murashita T; Yasuda K
    Nihon Kyobu Geka Gakkai Zasshi; 1996 Nov; 44(11):2019-26. PubMed ID: 8958717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the solutions of Bretschneider, St. Thomas' Hospital and the National Institutes of Health for cardioplegic protection during moderate hypothermic arrest.
    Kober IM; Obermayr RP; Brüll T; Ehsani N; Schneider B; Spieckermann PG
    Eur Surg Res; 1998; 30(4):243-51. PubMed ID: 9704750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histidine-tryptophan-ketoglutarate solution with added ebselen augments myocardial protection in neonatal porcine hearts undergoing ischemia/reperfusion.
    Chen Y; Liu J; Li S; Yan F; Xue Q; Wang H; Sun P; Long C
    Artif Organs; 2015 Feb; 39(2):126-33. PubMed ID: 25511318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined St. Thomas and histidine-tryptophan-ketoglutarat solutions for myocardial preservation in heart transplantation patients.
    Lee KC; Chang CY; Chuang YC; Sue SH; Yang HS; Weng CF; Lee YT; Huang WS; Chen IC; Wei J
    Transplant Proc; 2012 May; 44(4):886-9. PubMed ID: 22564575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardial protection with the use of L-arginine and N-alpha-acetyl-histidine.
    Koch A; Radovits T; Loganathan S; Sack FU; Karck M; Szabó GB
    Transplant Proc; 2009; 41(6):2592-4. PubMed ID: 19715981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardioprotective effect of nicorandil in histidine-tryptophan-ketoglurate solution during the cold storage of isolated hearts.
    Gu K; Kin S; Saitoh Y; Nosaka S; Sasaki T; Yamauchi M; Nakayama K
    Transplantation; 1996 Jun; 61(11):1572-5. PubMed ID: 8669099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eight hours of cold static storage with adenosine and lidocaine (Adenocaine) heart preservation solutions: toward therapeutic suspended animation.
    Rudd DM; Dobson GP
    J Thorac Cardiovasc Surg; 2011 Dec; 142(6):1552-61. PubMed ID: 21742347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative experimental study of myocardial protection with crystalloid solutions for heart transplantation.
    Lima ML; Fiorelli AI; Vassallo DV; Pinheiro BB; Stolf NA; Gomes OM
    Rev Bras Cir Cardiovasc; 2012; 27(1):110-6. PubMed ID: 22729308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.